| 000 | 01816 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517021844.0 | ||
| 264 | 0 | _c20160125 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1866-0452 | ||
| 024 | 7 |
_a10.3238/arztebl.2015.0121 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuderus, Stephan | |
| 245 | 0 | 0 |
_aInflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry. _h[electronic resource] |
| 260 |
_bDeutsches Arzteblatt international _cFeb 2015 |
||
| 300 |
_a121-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Distribution |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aChild Health _xstatistics & numerical data |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDiet Therapy _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEndoscopy, Gastrointestinal _xstatistics & numerical data |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesalamine _xtherapeutic use |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSex Distribution |
| 700 | 1 | _aScholz, Dietmar | |
| 700 | 1 | _aBehrens, Rolf | |
| 700 | 1 | _aClassen, Martin | |
| 700 | 1 | _aDe Laffolie, Jan | |
| 700 | 1 | _aKeller, Klaus-Michael | |
| 700 | 1 | _aZimmer, Klaus-Peter | |
| 700 | 1 | _aKoletzko, Sibylle | |
| 773 | 0 |
_tDeutsches Arzteblatt international _gvol. 112 _gno. 8 _gp. 121-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3238/arztebl.2015.0121 _zAvailable from publisher's website |
| 999 |
_c24697188 _d24697188 |
||